Skip to main content
. 2017 Jun 2;6:77. doi: 10.1186/s40249-017-0291-5

Table 5.

Treatment outcomes of tuberculosis patients diagnosed through mobile team activity in four regions and three states, Myanmar, October 2014-December 2014

Variable Total patients n (%) Initial lossa n Treatment success1 n (%) Failed n (%) Died n (%) LTFU2 n (%) Not evaluated n (%) Moved to SLD3 n (%)
All TB patients 504 20 (4.0) 438 (90.5) 7 (1.4) 13 (2.7) 13 (2.7) 9 (1.9) 4 (0.8)
New & Relapse 501 20 (4.0) 437 (90.5) 7 (1.5) 13 (2.7) 12 (2.5) 9 (1.9) 3 (0.6)
NSP PTB4 85 1 (1.2) 78 (91.8) 2 (2.4) 2 (2.4) 1 (1.2) 1 (1.2) 0 (0.0)
TB type
 SSP PTB5 108 2 (1.9) 93 (87.7) 4 (3.8) 3 (2.8) 2 (1.9) 1 (0.9) 3 (2.8)
 SSN PTB6 393 18 (4.6) 342 (91.2) 3 (0.8) 10 (2.7) 11 (2.9) 8 (2.1) 1 (0.3)
 EPTB7 3 0 3 (100)
TB category
 New 448 17 (3.8) 401 (93.0) 4 (0.9) 10 (2.3) 10 (2.3) 6 (1.4) 0 (0.0)
 Retreatment 56 3 (5.4) 37(66.0) 3 (6.3) 3 (6.3) 3 (6.3) 3 (6.3) 4 (7.1)
 Relapse 53 3 (5.4) 36 (72.0) 3 (6.0) 3 (6.0) 2 (4.0) 3 (6.0) 3 (6.0)
 LTFU2 3 0 1 (33.3) 0 (0.0) 0 (0.0) 1 (33.3) 0 (0.0) 1 (33.3)
Treatment
 IR8 416 15 (3.6) 371 (92.5) 4 (1.0) 10 (2.5) 10 (2.5) 6 (1.5) 0 (0.0)
 RR9 56 3 (5.4) 37 (69.8) 3 (5.7) 3 (5.7) 3 (5.7) 3 (5.7) 4 (7.5)
 CR10 32 2 (6.3) 30(100) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)

1Treatment Success includes patients who are cured and completed treatment

2LTFU: Loss-to-follow up; 3SLD: Second line drugs; 4NSP PTB: New smear positive PTB

5SSP PTB: Sputum smear positive Pulmonary TB 6 SSN PTB: Sputum smear negative Pulmonary TB; 7EPTB: Extra pulmonary TB 8IR: Initial Regimen 9RR: Retreatment Regimen 10CR: Childhood Regimen

aThis is calculated on total TB patients diagnosed while other outcomes excluding initial loss from the denominators